Kolexia
Lider Pauline
Pharmacien
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
39 Activités
277 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Maladie de Lyme Encéphalopathies Hypersensibilité médicamenteuse Hypersensibilité {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

Amgen
2 collaboration(s)
Dernière en 2022
Novartis
2 collaboration(s)
Dernière en 2022
Janssen
2 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Organizational and budgetary impacts of the implementation of CAR-T cell therapies in a French academic hospital.
Bulletin du cancer   05 septembre 2023
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
BMC cancer   25 novembre 2022
Ifosfamide-induced encephalopathy: Brand-name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®).
Journal of clinical pharmacy and therapeutics   04 mars 2019
First international database of research teams in stability and compatibility of medications: An additional function in the Stabilis database.
Annales pharmaceutiques francaises   19 septembre 2018
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.
European journal of hospital pharmacy : science and practice   07 juillet 2018
Pemetrexed stability: additional information about microparticles.
European journal of hospital pharmacy : science and practice   24 mai 2018
Incompatibility of busulfan with 1 ml Luer-Lock syringes.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   29 septembre 2015
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}